Accelerate the development of advanced biotherapeutics

Two scientists working in a research laboratory

Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity.

It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron Morena, Manager in Analytical Bioassay at Tanvex Biopharma CDMO, along with and Dr Neha Mishra, Senior Scientist in the BioProduction R&D team, Revvity. 

Successful development of advanced biotherapeutics relies on extensive characterization and tight quality control. Characterizing binding properties of complex biomolecules is a critical step. Biophysical data combined with functional assays are needed to predict efficacy and potency, optimise drug delivery, assess critical quality attributes, and improve biologics drug design.

Traditional approaches have limited use in a complex biological environment with multiple interactions. To address these challenges, our speakers have developed and implemented better performing and higher throughput technologies.

In this webinar, the speakers will discuss:

  • Method of testing the interaction of a lead biosimilar antibody candidate versus a commercially available antibody
  • Develop an assay to determine the level of binding activity
  • Utilisation of the assay in QC lot release
  • An expression platform to aid early-stage clone screening and protein characterisation
  • Higher-throughput platform to streamline cell line development and characterisation workflows

Register for free.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free